RT Book, Section
A1 Saseen, Joseph J.
A1 MacLaughlin, Eric J.
A2 DiPiro, Joseph T.
A2 Talbert, Robert L.
A2 Yee, Gary C.
A2 Matzke, Gary R.
A2 Wells, Barbara G.
A2 Posey, L. Michael
SR Print(0)
ID 1167762493
T1 Hypertension
T2 Pharmacotherapy: A Pathophysiologic Approach, 10e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259587481
LK accesspharmacy.mhmedical.com/content.aspx?aid=1167762493
RD 2024/04/19
AB Patient  Care  Process  for  the  Management  of  HypertensionCollectPatient  characteristics  (e.g.,  age,  race,  sex,  pregnant)Patient  history  (past  medical,  family,  social  —  dietary  habits,  tobacco  use)Home  blood  pressure  (BP)  readingsCurrent  medications  and  prior  anti-hypertensive  medication  useObjective  data  (see  Box  13-1)BP,  heart  rate  (HR),  height,  weight,  and  BMILabs  (e.g.  serum  electrolytes,  Scr,  BUN)Other  diagnostic  tests  when  indicated  (e.g.  ECG)AssessPresence  of  compelling  indications  (e.g.  coronary  artery  disease,  chronic  kidney  disease;  see  Figure  13-3)Hypertension-related  complications  (e.g.  albuminuria,  retinopathy;  see  Box  13-1)10-year  Atherosclerotic  cardiovascular  disease  (ASCVD)  risk  when  indicatedCurrent  medications  that  may  contribute  to  or  worsen  hypertensionBP  goal  and  whether  goal  has  been  achieved  (see  Box  13-2)Appropriateness  and  effectiveness  of  current  antihypertensive  regimenFor  resistant  hypertension  if  taking  3  or  more  antihypertensive  medications  (see  Table  13-10)Plan*Tailored  lifestyle  modifications  (e.g.  diet,  exercise,  weight  management;  see  Table  13-4)Drug  therapy  regimen  including  specific  antihypertensive(s),  dose,  route,  frequency,  and  duration;  specify  the  continuation  and  discontinuation  of  existing  therapies  (see  Tables  13-5,  13-6,  13-7,  and  13-9)Monitoring  parameters  including  efficacy  (e.g.  BP,  cardiovascular  events,  kidney  health),  safety  (medication-specific  adverse  effects),  and  timeframe  (see  Table  13-8)Patient  education  (e.g.  purpose  of  treatment,  dietary  and  lifestyle  modification,  drug  therapy)Self-monitoring  of  BP,  HR,  and  weight  —  where  and  how  to  record  resultsReferrals  to  other  providers  when  appropriate  (e.g.  physician,  dietician)Implement*Provide  patient  education  regarding  all  elements  of  treatment  planUse  motivational  interviewing  and  coaching  strategies  to  maximize  adherenceSchedule  follow-upFollow-up:  Monitor  and  EvaluateDetermine  BP  goal  attainmentPresence  of  adverse  effectsOccurrence  of  CV  events  and  development/progression  of  kidney  impairmentPatient  adherence  to  treatment  plan  using  multiple  sources  of  information*Collaborate  with  patient,  caregivers,  and  other  health  professionals